Ergomed's Richard Barfield highlights 'resilient performance' and strong momentum

Ergomed PLC's (LON:ERGO) Richard Barfield tells Proactive London's Andrew Scott they've made excellent progress in the first half of the year and adds that underlying earnings for the full-year are expected to be materially ahead of market expectations. They've reported first half revenue growth of 14.8% taking the total to £40.4mln while its order book expanded by 22% to £151.4mln in the period.